ArticleCureus2026
Pus-Forming Infections in an Advanced Care Hospital in Morocco: Enterobacterales Dominance With High Burden of Extended-Spectrum β-Lactamase Producers and Carbapenem Resistance.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and aim Pus-forming infections are a common cause of morbidity and are increasingly complicated by rising antimicrobial resistance (AMR). This study aimed to describe the bacteriological profile and antimicrobial resistance patterns of bacteria isolated from specimens in an advanced care hospital in Morocco, with a focus on multidrug resistant gram negative bacilli. Methods We conducted a single-centre, observational cross-sectional study from July 2024 to October 2025 in an advanced care hospital in Marrakech, Morocco. All pus specimens (fine-needle aspirates and wound swabs) received in the microbiology laboratory were processed using standard culture methods. Isolates were identified with the Phoenix™ M50 system, and antimicrobial susceptibility testing was conducted by Phoenix™ M50 and disk diffusion, interpreted according to Comité de l'Antibiogramme de la Société Française de Microbiologie (CA-SFM)/European Committee on Antimicrobial Susceptibility Testing (EUCAST) 2025 guidelines. Categorical variables were expressed as counts and percentages; comparisons of proportions were made using the chi-square test or Fisher's exact test when appropriate, with p < 0.05 considered significant. Results Among 469 specimens, 269 yielded bacterial growth (culture positivity rate 57.35%), corresponding to 309 isolates. Most culture positive patients were male (84.01%) and between 60-80 years (55.39%); 92.6% were inpatients. Fine needle aspirates had a higher positivity rate than swabs (60.1% vs 44.2%; p = 0.01). Infections were mainly monomicrobial (83.27%). Gram-negative organisms were the most frequent (66.66%), while gram-positive organisms represented 33.33%. The most frequent pathogens were
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.